相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis
Carmen Tur et al.
JAMA NEUROLOGY (2023)
Associations of sNfL with clinico-radiological measures in a large MS population
Elias S. Sotirchos et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
Jaume Sastre-Garriga et al.
NATURE REVIEWS NEUROLOGY (2020)
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Ludwig Kappos et al.
JAMA NEUROLOGY (2020)
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
Lauren Strober et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Cognition in multiple sclerosis: State of the field and priorities for the future
James F. Sumowski et al.
NEUROLOGY (2018)
Information processing speed in multiple sclerosis: Past, present, and future
Silvana L. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Information processing speed in multiple sclerosis: Past, present, and future
Silvana L. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
Maria A. Rocca et al.
LANCET NEUROLOGY (2015)
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2014)
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
T. L. Vollmer et al.
JOURNAL OF NEUROLOGY (2014)
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
Maria Pia Sormani et al.
LANCET NEUROLOGY (2013)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis
Maria Pia Amato et al.
ARCHIVES OF NEUROLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi et al.
NEUROLOGY (2005)
Dehydration confounds the assessment of brain atrophy
T Duning et al.
NEUROLOGY (2005)
Minimal neuropsychological assessment of MS patients: A consensus approach
RHB Benedict et al.
CLINICAL NEUROPSYCHOLOGIST (2002)
分享论文
